Arbutus Biopharma and Genevant Sciences have filed multiple patent infringement lawsuits against Pfizer and BioNTech over ...

Arbutus Biopharma and its licensee Genevant filed three patent infringement lawsuits against Pfizer and BioNTech for its lipid nanoparticle technology. The clinical-stage biopharmaceutical company is ...

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2026 on Tuesday, August 4, 2026. Additionally, the Company will host a conference ...

Pfizer's non-oncology portfolio faced mixed Q2 trends. Eliquis and Vyndaqel sales may have risen while COVID products will ...

Warminster-based Arbutus Biopharma has cranked up its legal war over COVID‑19 vaccine delivery technology, rolling out a new ...

A former Goldman Sachs executive has joined the Chester County biotechnology company as chief financial officer.

The two New Jersey suits assert eight patents against Pfizer and 10 against Moderna, extending existing mRNA litigation ...

Moderna has countered a patent-infringement lawsuit brought by biotech company CureVac in Delaware federal court over its ...

The State of Oregon and the nonprofit healthcare system PeaceHealth both issued mandates in 2021 requiring healthcare workers ...

Summit Therapeutics has released more Phase III trial data for ivonescimab in non-small cell lung cancer (NSCLC) as it awaits ...

Malaysian Prime Minister Muhyiddin Yassin tendered his resignation to the king on Monday, becoming the shortest-ruling leader ...

While the Lodi School Board has approved the final wording for the referendum to appear on this fall's ballots, the district ...